These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35185544)

  • 21. miR-1224 contributes to ischemic stroke-mediated natural killer cell dysfunction by targeting Sp1 signaling.
    Feng Y; Li Y; Zhang Y; Zhang BH; Zhao H; Zhao X; Shi FD; Jin WN; Zhang XA
    J Neuroinflammation; 2021 Jun; 18(1):133. PubMed ID: 34118948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE(-/-) Mice Induced by Hyperlipaemia.
    Qin H; Liu P; Lin S
    Evid Based Complement Alternat Med; 2015; 2015():385154. PubMed ID: 26074989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astragaloside IV inhibits adriamycin-induced cardiac ferroptosis by enhancing Nrf2 signaling.
    Luo LF; Guan P; Qin LY; Wang JX; Wang N; Ji ES
    Mol Cell Biochem; 2021 Jul; 476(7):2603-2611. PubMed ID: 33656642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia.
    Luo Y; Qin Z; Hong Z; Zhang X; Ding D; Fu JH; Zhang WD; Chen J
    Neurosci Lett; 2004 Jun; 363(3):218-23. PubMed ID: 15182947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effects of astragaloside IV and
    Essawy AE; Abd Elkader HAE; Khamiss OA; Eweda SM; Abdou HM
    PeerJ; 2021; 9():e11930. PubMed ID: 34434659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway.
    Xu Z; Liu W; Huang H
    Pharmacology; 2020; 105(3-4):181-189. PubMed ID: 31825924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.
    Xu C; Tang F; Lu M; Yang J; Han R; Mei M; Hu J; Zhou M; Wang H
    Int Immunopharmacol; 2016 Apr; 33():119-27. PubMed ID: 26903414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Astragaloside IV alleviates liver injury in type 2 diabetes due to promotion of AMPK/mTOR‑mediated autophagy.
    Zhu Y; Su Y; Zhang J; Zhang Y; Li Y; Han Y; Dong X; Li W; Li W
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation
    Zhu H; Jian Z; Zhong Y; Ye Y; Zhang Y; Hu X; Pu B; Gu L; Xiong X
    Front Immunol; 2021; 12():714943. PubMed ID: 34367186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
    Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Astragaloside IV inhibits isoprenaline‑induced cardiac fibrosis by targeting the reactive oxygen species/mitogen‑activated protein kinase signaling axis.
    Dai H; Jia G; Lu M; Liang C; Wang Y; Wang H
    Mol Med Rep; 2017 Apr; 15(4):1765-1770. PubMed ID: 28260010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel microbial and hepatic biotransformation-integrated network pharmacology strategy explores the therapeutic mechanisms of bioactive herbal products in neurological diseases: the effects of Astragaloside IV on intracerebral hemorrhage as an example.
    Hu E; Li Z; Li T; Yang X; Ding R; Jiang H; Su H; Cheng M; Yu Z; Li H; Tang T; Wang Y
    Chin Med; 2023 Apr; 18(1):40. PubMed ID: 37069580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xuesaitong May Protect Against Ischemic Stroke by Modulating Microglial Phenotypes and Inhibiting Neuronal Cell Apoptosis via the STAT3 Signaling Pathway.
    Li F; Zhao H; Han Z; Wang R; Tao Z; Fan Z; Zhang S; Li G; Chen Z; Luo Y
    CNS Neurol Disord Drug Targets; 2019; 18(2):115-123. PubMed ID: 30426907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy.
    Luo LF; Qin LY; Wang JX; Guan P; Wang N; Ji ES
    Front Pharmacol; 2021; 12():669782. PubMed ID: 34108879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway.
    Nie P; Meng F; Zhang J; Wei X; Shen C
    Oxid Med Cell Longev; 2019; 2019():4625912. PubMed ID: 31285785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration.
    Sun R; Zhang A; Ge Y; Gou J; Yin T; He H; Wang Y; Zhang G; Kong J; Shang L; Tao X; Zhang Y; Tang X
    Expert Opin Drug Deliv; 2020 Sep; 17(9):1305-1320. PubMed ID: 32538226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway.
    Lu M; Tang F; Zhang J; Luan A; Mei M; Xu C; Zhang S; Wang H; Maslov LN
    Phytother Res; 2015 Apr; 29(4):599-606. PubMed ID: 25604645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AIM2 deletion enhances blood-brain barrier integrity in experimental ischemic stroke.
    Xu SY; Bian HJ; Shu S; Xia SN; Gu Y; Zhang MJ; Xu Y; Cao X
    CNS Neurosci Ther; 2021 Oct; 27(10):1224-1237. PubMed ID: 34156153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astragaloside IV blocks monocrotaline‑induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling.
    Jin H; Jiao Y; Guo L; Ma Y; Zhao R; Li X; Shen L; Zhou Z; Kim SC; Liu J
    Int J Mol Med; 2021 Feb; 47(2):595-606. PubMed ID: 33416126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study on inhibition of total astragalus saponins and astragaloside IV on TNFR1-mediated signaling pathways in arterial endothelial cells.
    Liu QS; Wang HF; Sun AK; Huo XP; Liu JL; Ma SH; Peng N; Hu J
    PLoS One; 2014; 9(7):e101504. PubMed ID: 24991819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.